98 related articles for article (PubMed ID: 16184836)
1. Behcet's disease is associated with increased concentrations of antibodies against phosphatidylserine and ribosomal phosphoproteins.
Berlit P; Stueper B; Fink I; Rebmann V; Hoyer P; Kreuzfelder E; Grosse-Wilde H
Vasa; 2005 Aug; 34(3):176-80. PubMed ID: 16184836
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease.
Vural B; Sehitoğlu E; Cavuş F; Yalçınkaya N; Haytural H; Küçükerden M; Ulusoy C; Uğurel E; Turan S; Bulut L; Türkoğlu R; Shugaiv E; Kürtüncü M; Atakan S; Güre AO; Gül A; Eraksoy M; Akman-Demir G; Tüzün E
J Neuroimmunol; 2013 Oct; 263(1-2):139-44. PubMed ID: 24035008
[TBL] [Abstract][Full Text] [Related]
3. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.
Bassyouni IH; Gamal S; Talaat RM; Siam I
Mod Rheumatol; 2014 Mar; 24(2):316-20. PubMed ID: 24593207
[TBL] [Abstract][Full Text] [Related]
5. Anti-cardiolipin and anti-Neutrophil Cytoplasmic Antibodies in Iranian patients with Behcet's disease.
Ataollahi MR; Aflaki E; Nazarinia MA; Shenavandeh S; Habibagahi Z; Gharesi-Fard B; Kamali-Sarvestani E
Iran J Immunol; 2012 Dec; 9(4):241-7. PubMed ID: 23268290
[TBL] [Abstract][Full Text] [Related]
6. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
7. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
8. Markers of vascular injury in Behçet's disease associated with retinal vasculitis.
Pivetti-Pezzi P; Priori R; Catarinelli G; Meroni PL; Federici AB; Abdulaziz M; Falco M; Valesini G
Ann Ophthalmol; 1992 Nov; 24(11):411-4. PubMed ID: 1476395
[TBL] [Abstract][Full Text] [Related]
9. HLA-B*27 allele associated to Behçet's disease and to anterior uveitis in Moroccan patients.
Radouane A; Oudghiri M; Chakib A; Naya A; Belhouari A; El Malki A; Bennani S
Ann Biol Clin (Paris); 2011; 69(4):419-24. PubMed ID: 21896406
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen in Sweet's syndrome and its relationship to Behçet's disease.
Mizoguchi M; Matsuki K; Mochizuki M; Watanabe R; Ogawa K; Harada S; Hino H; Amagai M; Juji T
Arch Dermatol; 1988 Jul; 124(7):1069-73. PubMed ID: 3389850
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients.
Hamzaoui A; Houman MH; Massouadia M; Ben Salem T; Khanfir MS; Ben Ghorbel I; Miled M
Eur J Intern Med; 2012 Jun; 23(4):347-9. PubMed ID: 22560383
[TBL] [Abstract][Full Text] [Related]
12. Identification of prohibitin as an antigen in Behcet's disease.
Xun Y; Chen P; Yan H; Yang W; Shi L; Chen G; Du H
Biochem Biophys Res Commun; 2014 Aug; 451(3):389-93. PubMed ID: 25091478
[TBL] [Abstract][Full Text] [Related]
13. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
[TBL] [Abstract][Full Text] [Related]
14. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
15. Alpha tropomyosin as a self-antigen in patients with Behçet's disease.
Mahesh SP; Li Z; Buggage R; Mor F; Cohen IR; Chew EY; Nussenblatt RB
Clin Exp Immunol; 2005 May; 140(2):368-75. PubMed ID: 15807864
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
[TBL] [Abstract][Full Text] [Related]
20. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
Sakly N; Boumiza R; Zrour-Hassen S; Hamzaoui A; Ben Yahia S; Amara H; Khairallah M; Mahjoub S; Bergaoui N; Ghedira I
Ann N Y Acad Sci; 2009 Sep; 1173():564-9. PubMed ID: 19758200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
